| Jamie Brubaker Mcconnell, MHP | |
|
9330 59th Ave Sw, Lakewood, WA 98499-2858 | |
| (253) 581-7020 | |
| Not Available |
| Full Name | Jamie Brubaker Mcconnell |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 9330 59th Ave Sw, Lakewood, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033850771 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | SC60777491 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jamie Brubaker Mcconnell, MHP 4215 Olympic Blvd W, University Place, WA 98466-7538 Ph: (206) 979-4421 | Jamie Brubaker Mcconnell, MHP 9330 59th Ave Sw, Lakewood, WA 98499-2858 Ph: (253) 581-7020 |
News Archive
DW Healthcare Partners, a healthcare-focused private equity firm with offices in Toronto, Ontario and Park City, Utah, announced the sale of its portfolio company, Career Step Holdings, LLC to Revelstoke Capital Partners, a Denver-based private equity firm. The terms of the transaction were not disclosed.
Some expectant parents play classical music for their unborn babies, hoping to boost their children's cognitive capacity later in life.
Doctors agree that vitamin D promotes bone health, but a belief that it can also prevent cancer, cardiovascular disease and other causes of death has been a major health controversy. Consistent with advice issued last fall by the Institute of Medicine, a new study finds that vitamin D did not confer benefits against mortality in postmenopausal women after controlling for key health factors such as abdominal obesity.
Northwest Biotherapeutics (NASDAQ: NWBO)(NW Bio), a biotechnology company developing non-toxic DCVax® personalized immune therapies for solid tumor cancers, announced today that it has received a decision from the German regulatory agency (the Paul Ehrlich Institute, or PEI) under which the Company's Phase III clinical trial will be able to proceed in Germany after the Company makes three modifications, none of which affect the body of the trial or the bases for seeking product approval.
Alkermes plc today announced positive topline results from a randomized, double-blind, placebo-controlled phase 3 clinical trial of aripiprazole lauroxil in patients with schizophrenia. Patients treated once monthly with either 441 mg or 882 mg of aripiprazole lauroxil demonstrated statistically significant reductions from baseline in Positive and Negative Syndrome Scale (PANSS) total scores at week 12, compared to placebo (p<0.001 aripiprazole lauroxil 441 mg, p<0.001 aripiprazole lauroxil 882 mg), which was the prespecified primary endpoint in the study. Based on the positive results from this phase 3 study, Alkermes plans to submit a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) in the third quarter of 2014.
› Verified 3 days ago
Miss Shakima L Tozay, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 9108 Lakewood Dr Sw, Lakewood, WA 98499 Phone: 253-581-6202 | |
Keith John Mcneal, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 5900 100th St Sw Ste 17b, Lakewood, WA 98499 Phone: 253-431-9739 | |
Joseph Terrell Gilmore, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 5900 100th St Sw Ste 16, Lakewood, WA 98499 Phone: 915-760-9526 | |
Emily Kathryn Smith, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 5900 100th St Sw Ste 17b, Lakewood, WA 98499 Phone: 253-625-5942 | |
Mrs. Amy Melissa Geforos, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 9330 59th Ave Sw, Lakewood, WA 98499 Phone: 253-756-2913 Fax: 253-756-2681 | |
Dr. Jack D Williamson, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 5126 80th St Sw, Lakewood, WA 98499 Phone: 253-476-1234 |